Short Interest in EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Drops By 79.3%

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) saw a significant drop in short interest during the month of June. As of June 30th, there was short interest totaling 39,841 shares, a drop of 79.3% from the June 15th total of 192,041 shares. Based on an average daily volume of 280,156 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are short sold.

EssilorLuxottica Stock Performance

Shares of OTCMKTS:ESLOY traded down $1.89 during trading on Monday, hitting $95.90. The company’s stock had a trading volume of 77,166 shares, compared to its average volume of 121,659. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70. The company has a 50-day moving average of $100.52 and a 200-day moving average of $123.65. EssilorLuxottica has a 12 month low of $91.57 and a 12 month high of $186.81.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of EssilorLuxottica in a research report on Tuesday, May 12th. They issued a “hold” rating for the company. Zacks Research downgraded EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.